Both urokinase-like plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor (PAI-1), as well as uPA–PAI-1 complexes, have been identified as important prognostic factors in breast cancer. The gene discussed is SERPINE1; the disease is breast carcinoma.